Chart calendar Merck & Co., Inc.

43ade.BPtfSLIhaas1TMBIGw2DN4gZ2yVjnDGUXQYWlRGz2H0.c7cbMcRJJMFWKpgRfkW0WNlO6xIu8kTRB1lZwyKDgCsplC0c9HAH5XQO-A~92f8cb85f617cbbc832fef8890219d30

Upcoming events on Merck & Co., Inc.

2026-02-03

Q4 2025 Earnings Release

2026-02-03

Q4 2025 Earnings Call

2026-04-30

Q1 2026 Earnings Release

2026-04-30

Q1 2026 Earnings Call

2026-08-03

Q2 2026 Earnings Release

2026-08-04

Q2 2026 Earnings Call

2026-10-29

Q3 2026 Earnings Release

2026-10-29

Q3 2026 Earnings Call

2027-02-03

Q4 2026 Earnings Release (Projected)

2027-04-28

Q1 2027 Earnings Release (Projected)

2027-08-02

Q2 2027 Earnings Release (Projected)

2027-11-03

Q3 2027 Earnings Release (Projected)

Past events on Merck & Co., Inc.

2026-01-12

J.P. Morgan Healthcare Conference

2025-12-14

Ex-dividend day

2025-12-03

Citi Global Healthcare Conference

2025-12-03

Clinical Trials on Alzheimer Disease Conference - Abstract Number P249

2025-12-02

Clinical Trials on Alzheimer Disease Conference - Abstract Number P112

2025-12-02

Evercore Healthcare Conference

2025-12-01

Clinical Trials on Alzheimer Disease Conference - Abstract Number P112

2025-11-20

Jefferies Global Healthcare Conference

2025-11-17

Acquisition of Cidara Therapeutics, Inc. by Merck & Co., Inc. Call

2025-11-10

American Heart Association Meeting - Abstract Number: 4341629

2025-11-09

American Heart Association Meeting

2025-11-09

American Heart Association Meeting - Abstract Number: 4391641

2025-11-09

American Heart Association Meeting - Abstract Number: 4359798

2025-11-08

American Heart Association Meeting - Abstract Number: 4391578

2025-11-08

American Heart Association Meeting - Abstract Number: 4365782

2025-11-08

American Heart Association Meeting - Abstract Number: 4387511

2025-10-30

Q3 2025 Earnings Call

2025-10-30

Q3 2025 Earnings Release

2025-10-18

European AIDS Conference

2025-10-17

European AIDS Conference

Past dividends on Merck & Co., Inc.

2025-12-14

Quarterly 0.85 USD

2025-09-14

Quarterly 0.81 USD

2025-06-15

Quarterly 0.81 USD

2025-03-16

Quarterly 0.81 USD

2024-12-15

Quarterly 0.81 USD

2024-09-15

Quarterly 0.77 USD

2024-06-16

Quarterly 0.77 USD

2024-03-13

Quarterly 0.77 USD

2023-12-13

Quarterly 0.77 USD

2023-09-13

Quarterly 0.73 USD

2023-06-13

Quarterly 0.73 USD

2023-03-13

Quarterly 0.73 USD

2022-12-13

Quarterly 0.73 USD

2022-09-13

Quarterly 0.69 USD

2022-06-13

Quarterly 0.69 USD

2022-03-13

Quarterly 0.69 USD

2021-12-13

Quarterly 0.69 USD

2021-09-13

Quarterly 0.65 USD

2021-06-13

Quarterly 0.65 USD

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million USD
Released
Forecast
Spread
59 283
59 144
0.24%
60 115
59 938
0.3%
64 168
63 997
0.27%

64 791


67 677


71 188

EBITDA
Million USD
Released
Forecast
Spread
26 431
24 588
7.5%
10 083
9 362
7.71%
27 897
26 650
4.68%

29 969


23 875


33 606

EBIT
Million USD
Released
Forecast
Spread
22 522
22 363
0.71%
6 211
6 066
2.4%
23 398
23 593
-0.83%

26 731


20 288


30 219

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
16 444
17 389
-5.44%
1 889
2 857
-33.89%
19 936
21 364
-6.68%

22 811


18 332


28 065

Net income
Million USD
Released
Forecast
Spread
14 519
14 827
-2.07%
365
1 682
-78.3%
17 117
17 500
-2.19%

20 084


14 475


22 613

EPS
USD
Released
Forecast
Spread
5,71
5,87
-2.73%
0,14
0,56
-75.16%
6,74
7,01
-3.82%

7,81


5,67


9,22

Announcement Date02/02/2301/02/2404/02/25-

Quarterly results

Fiscal PeriodSeptember 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3
Net sales
Million USD
Released
Forecast
Spread
15 775
15 204
3.75%
16 112
15 844
1.69%
16 657
16 514
0.87%
15 624
15 507
0.76%
15 529
15 331
1.29%
15 806
15 873
-0.42%
17 276
16 978
1.76%

16 201


15 908


16 498


17 897


17 025


16 985


17 730


19 160

EBITDA
Million USD
Released
Forecast
Spread
7 367
6 562
12.27%
7 177
7 367
-2.57%
5 466
5 999
-8.89%
6 422
7 737
-16.99%
7 722
6 882
12.2%
7 484
7 160
4.52%
8 710
8 313
4.77%

7 996


2 996


7 795


9 213













EBIT
Million USD
Released
Forecast
Spread
6 383
5 808
9.91%
6 659
6 519
2.14%
4 913
5 046
-2.63%
5 225
5 140
1.66%
6 623
6 533
1.38%
6 365
6 206
2.56%
7 556
7 139
5.84%

6 192


1 975


6 725


7 946


6 241










Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
5 670
5 267
7.66%
6 006
6 023
-0.29%
4 090
4 535
-9.82%
4 170
4 641
-10.15%
5 903
5 880
0.4%
4 999
5 672
-11.86%
6 745
6 465
4.32%

4 438






















Net income
Million USD
Released
Forecast
Spread
4 762
4 414
7.88%
5 455
4 942
10.38%
3 157
3 419
-7.66%
3 743
3 700
1.16%
5 079
4 983
1.93%
4 427
4 651
-4.81%
5 785
5 155
12.22%

4 274


-1 883


5 924


6 976













EPS
USD
Released
Forecast
Spread
1,87
1,79
4.45%
2,14
1,93
10.86%
1,24
1,43
-13.39%
1,48
1,49
-0.58%
2,01
1,93
3.97%
1,76
1,84
-4.45%
2,32
2,06
12.85%

1,61






















Announcement Date25/04/2430/07/2431/10/2404/02/2524/04/2529/07/2530/10/25--------
2026-01-27

Q3 2026 Earnings Release

2026-01-27

Q3 2025 Earnings Release

2026-01-27

Q3 2026 Earnings Release

2026-01-27

Q3 2026 Earnings Release (Projected)

2026-01-28

Q4 2025 Earnings Release

2026-01-28

Q4 2025 Earnings Release

2026-01-29

Q4 2025 Earnings Release

2026-01-29

Q3 2025 Earnings Release

2026-01-29

Q4 2025 Earnings Release

2026-01-29

Q3 2025 Earnings Release

More events

Past sector events for Merck & Co., Inc.

2026-01-23

Q3 2026 Earnings Release

2026-01-23

Q3 2026 Earnings Release

2026-01-22

Q3 2026 Earnings Release

2026-01-21

Q3 2026 Earnings Release (Projected)

2026-01-21

Q3 2026 Earnings Release

2026-01-21

Q4 2025 Earnings Release

2026-01-20

Q4 2025 Earnings Release

2026-01-16

Q3 2026 Earnings Release

2026-01-15

Q3 2026 Earnings Release (Projected)

2026-01-12

December 2025 Sales and Revenue Release

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MRK Stock
  4. Calendar Merck & Co., Inc.